In a report released today, Jason Wittes from Roth MKM maintained a Buy rating on Orthofix (OFIX – Research Report), with a price target of $22.00. The company’s shares closed today at $10.71.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Wittes covers the Healthcare sector, focusing on stocks such as Allurion Technologies, Monogram Orthopaedics Inc, and Orthofix. According to TipRanks, Wittes has an average return of 3.6% and a 49.43% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Orthofix with a $23.33 average price target.
The company has a one-year high of $20.73 and a one-year low of $10.50. Currently, Orthofix has an average volume of 343.7K.
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OFIX in relation to earlier this year. Last month, Engine Capital Management, LP, a Major Shareholder at OFIX bought 100,000.00 shares for a total of $1,231,000.00.
Read More on OFIX: